Pfizer - food industry company news 
AFRICA/AUS: Aspen to buy Pfizer infant assets in Nestle deal
19 April 2013
Aspen Pharmacare is to acquire the Pfizer infant nutrition businesses in Australia and southern Africa after a deal with Nestle worth US$215m.
MEXICO: Nestle to sell Pfizer assets to settle competition concerns
16 April 2013
Nestle will sell Pfizer's Mexican business to settle competition issues in the market arising from its deal last year to buy the pharmaceutical giant's infant nutrition operations worldwide.
just-food confidence survey - China dominates emerging market interest
2 April 2013
just-food's Confidence Survey asked for your views on the emerging markets and, in particular, which of the BRIC economies you expected to offer the greatest opportunity in 2013. While the BRICs continued to offer opportunity for most multi-nationals, other markets such as Indonesia and Vietnam are emerging as focus markets for the future.
just-food confidence survey: M&A appetite grows but will deals be done?
2 April 2013
just-food's industry confidence survey for 2013 indicated an increased appetite for M&A this year after what some saw, globally, as a lacklustre year in the sector for deals. What lies ahead in the mergers and acquisitions arena over the next few months?
EXCLUSIVE: CAGE: Mead Johnson upbeat on China despite Nestle expansion
21 March 2013
Mead Johnson has dismissed any suggestions Nestle will prove to be formidable competition in China following the Swiss food group's acquisition of Pfizer's baby food business.
CAGE: Mead Johnson confident on 2013 despite "tough comparables"
21 March 2013
US infant nutrition group Mead Johnson says it is facing tough comparables this year due to pricing problems in China in 2012 but said it expects a rebound in growth in the back half of 2013.
CAGNY: Nestle eyes resurgence in US infant nutrition
21 February 2013
Swiss food giant Nestle has said it hopes to "come back strongly" in infant nutrition in the US, where it believes a "postponed birth spurt" could drive growth of the category.
In the spotlight: Heinz's prospects under 3G and Buffett
15 February 2013
Heinz stunned the global food industry with news it had agreed to a US$28bn takeover offer from Warren Buffett's Berkshire Hathaway fund and private-equity firm 3G Capital - purported to be the largest-ever deal in the sector. Dean Best looks at what could lie ahead for the US food giant.
Editor's choice: the highlights on just-food last week
11 February 2013
One story has dominated the industry headlines last week - the deepening and widening horse meat contamination, which has now taken in household brand Findus and a supplier in France. Beyond the debate over food standards and the scrutiny of the supply chain, Dairy Crest admitted it was struggling to find suitable M&A targets, Marks and Spencer said its Simply Food ambitions could lead them beyond France and further into Europe, while Kellogg insisted it was seeing improvement in its business in the region.
Quote, unquote: just-food's week in words
11 February 2013
Few stories in recent months have caused as much comment as the horse meat scandal, which last week deepened with the news Findus lasagne sold in the UK contained the ingredient. Elsewhere, Dairy Crest said potential takeover targets wanted too much money, Nestle found another country looking at the implications of its Pfizer infant formula acquisition and Kraft Foods Group went to court over the Cracker Barrel trademark.
SOUTH AFRICA: Competition watchdog to assess Nestle-Pfizer merger
5 February 2013
South Africa's Competition Commission will recommend the Competition Tribunal approve the South African leg of Nestle's global acquisition of Pfizer Nutrition, with a number of conditions, at a hearing tomorrow (6 February).
just-food's outlook for 2013: Mega deals unlikely as consolidation continues
31 January 2013
There may be caution over the prospect for blockbuster deals in a dilapidated economic environment, but the food sector mergers and acquisitions table still has plenty to whet the appetite.
SWITZERLAND: Nestle quiet on assets sale speculation
9 January 2013
Nestle has declined to comment on a report claiming it could sell US$1bn of assets in Latin America in order to secure final regulatory approvals for its Pfizer nutrition unit acquisition.
just-food review of 2012: M&A revival but caution hinders big deals
19 December 2012
There were, despite continued economic uncertainty in many Western markets and concerns over slowing growth in the East, signs that M&A activity rebounded in the food sector this year. However, a look at just-food's M&A coverage this year shows there have been few big-ticket, transformational deals.
MEXICO/AUS: Anti-trust concerns hit Nestle-Pfizer deal
22 November 2012
Nestle's acquisition of Pfizer's infant nutrition has been blocked by Mexico's anti-trust authority and had conditions attached to it by Australia's competition regulator.
Focus: Nestle Health Science sneaks under the radar
10 August 2012
Nestle's health science division has continued to motor below the radar in the first half of 2012 and the group is confident of a bright future for the unit.
On the money: Nestle says innovation "key" to growth in mature markets
9 August 2012
Nestle has said innovation is key to growth in developed markets where the company says achieving higher sales is "no walk in the park".
just-food Confidence Survey - emerging markets and sustainability
30 April 2012
just-food's Confidence Survey also included questions on the emerging markets and sustainability. Of the BRIC markets, China gave respondents most cause for optimism. Outside those four countries, markets from Colombia to Vietnam filled others with confidence. And, on the issue of sustainability, alleviating their company's impact on the environment remained a priority for many despite the gloomy economic landscape.
Comment: Nestle turns to emerging markets, Wal-Mart allegations hit the top
30 April 2012
Last week started with a bang, when on Monday morning (23 April) Nestle announced that it had beaten off competition from the likes of Danone to secure the baby food business of US pharmaceuticals group Pfizer.
Editor's choice: the highlights on just-food this week
30 April 2012
Allegations of bribery at Wal-Mart Stores' Mexican arm grabbed the headlines at the start of the week, rocking the world's largest retailer. Nestle, the world's largest food manufacturer, made waves of its own with its US$11.9bn deal to buy Pfizer's baby food business. The week also saw a raft of first-quarter results and the announcement of the latest results from Unilever's Sustainable Living Plan, a programme to reduce its impact on the environment. We met Unilever CEO Paul Polman to discuss the company's progress.
Quote, unquote: just-food's week in words
30 April 2012
Unilever CEO Paul Polman is one of the most prominent advocates of companies pursuing an agenda of sustainability and this week he outlined the company's progress. Meanwhile, Wal-Mart Stores was forced to react to claims of bribery in its Mexican operations and Nestle's acquisition of Pfizer's baby food business was scrutinised by analysts. The investment community also had a raft of first-quarter results to get their teeth into, with Kellogg, PepsiCo, Premier Foods plc and Hershey among the companies reporting.
CHINA: Heinz to build Sanshui baby food facility
25 April 2012
Heinz has signed an investment agreement with the government of the Sanshui district in the Chinese city of Foshan for the construction of a baby food manufacturing base.
In the spotlight: Nestle's Pfizer buy offers long-term baby food boost
23 April 2012
Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.
US: Nestle acquires Pfizer baby food arm for US$11.85bn
23 April 2012
Nestle has agreed a deal to acquire the infant nutrition business of US pharmaceuticals group Pfizer for US$11.85bn.
Comment: Nestle pays the piper with Pfizer deal
23 April 2012
Announcing its US$11.85bn acquisition of Pfizer's baby food unit this morning (23 April), it was interesting to note that Nestle took a slightly unusual tact in presenting the deal multiples.
Editor's choice: the highlights on just-food this week
23 April 2012
Tesco's plan to win back UK consumers understandably grabbed the headlines this week but there was plenty to analyse elsewhere. Nestle featured in the latest M&A speculation, with rumours that a deal to buy Pfizer's baby food unit was near and talk that it could sell its ice cream business in Australia. The food giant also kicked off the run of results announcements for the first quarter and joined Danone in outlining the challenges of operating in weak developed markets. Click on the headlines for more.
Quote, unquote: just-food's week in words
23 April 2012
A raft of first-quarter results stories this week from the likes of Danone and Nestle, and full-year results from Tesco have kept analysts busy.
FRANCE: Danone "raises offer for Pfizer baby food unit"
20 April 2012
French food giant Danone has reportedly raised its offer for the infant nutrition business of US pharmaceutical group Pfizer.
Comment: Could Pfizer be playing hardball over baby food?
19 April 2012
Anticipation is mounting over the likely sale of Pfizer's baby food business, with an announcement widely expected next week.
UPDATE 2: US: Pfizer seeks "maximum value" from baby food unit
18 April 2012
US pharmaceutical group Pfizer has insisted it will get maximum value for its shareholders out of any move to separate its infant nutrition business.
